Drug profile · INN
simoctocog alfa
NUWIQ
simoctocog alfa (NUWIQ) is a coagulation factor viii exogenous protein.
EMA: approved Blood and blood forming organs (B02) B02BD02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — simoctocog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
simoctocog alfa (NUWIQ) is a coagulation factor viii exogenous protein.
Key facts
INN simoctocog alfa
Brand NUWIQ
Mechanism Coagulation factor VIII exogenous protein
Target Coagulation factor VIII
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD02
Mechanism of action
Coagulation factor VIII exogenous protein
Primary target: Coagulation factor VIII
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is simoctocog alfa?
simoctocog alfa (NUWIQ) is a coagulation factor viii exogenous protein.
What is the brand name for simoctocog alfa?
NUWIQ is a marketed brand name for simoctocog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.